The expression of immediate early genes (IEGs) is thought to be an essential molecular basis of neuronal plasticity for higher brain function. Many IEGs contain serum response element in their transcriptional regulatory regions and their expression is controlled by serum response factor (SRF). SRF is known to play a role in concert with transcriptional cofactors. However, little is known about how SRF cofactors regulate IEG expression during the process of neuronal plasticity. We hypothesized that one of the SRF-regulated neuronal IEGs, activity-regulated cytoskeleton-associated protein (Arc; also termed Arg3.1), is regulated by an SRF coactivator, megakaryoblastic leukemia (MKL). To test this hypothesis, we initially investigated which binding site of the transcription factor or SRF cofactor contributes to brainderived neurotrophic factor (BDNF)-induced Arc gene transcription in cultured cortical neurons using transfection and reporter assays. We found that BDNF caused robust induction of Arc gene transcription through a cAMP response element, binding site of myocyte enhancer factor 2, and binding site of SRF in an Arc enhancer, the synaptic activityresponsive element (SARE). Regardless of the requirement for the SRF-binding site, the binding site of a ternary complex factor, another SRF cofactor, did not affect BDNF-mediated Arc gene transcription. In contrast, chromatin immunoprecipitation revealed occupation of MKL at the SARE. Furthermore, knockdown of MKL2, but not MKL1, significantly decreased BDNF-mediated activation of the SARE. Taken together, these findings suggest a novel mechanism by which MKL2 controls the Arc SARE in response to BDNF stimulation. Lines of evidence suggest that the expression of immediate early genes (IEGs), which encode transcription factors, neuronal signaling molecules and synaptic proteins, is required for normal brain development and function (Greer
and Greenberg 2008; Okuno 2011). IEG expression is implicated in long-lasting changes in neuronal properties that underlie learning and memory formation Fleischmann et al. 2003; Inoue et al. 2009; Jones et al. 2001; Bozon et al. 2003) . Thus, to date, huge efforts have been invested to elucidate the molecular mechanism of IEG expression regulation at the transcriptional level for better understanding of neuronal plasticity and brain function (Greer and Greenberg 2008; Tao et al. 1998; Tabuchi et al. 2002) .
The activity-regulated cytoskeleton-associated protein (Arc) gene (also termed Arg3.1) is known as a pivotal and neuronal IEG (Okuno 2011; Lyford et al. 1995) . Molecular functions of Arc are proposed to be associated with the downregulation of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA)-type glutamate receptors from the synaptic membrane (Chowdhury et al. 2006; Okuno et al. 2012) . Arc expression in the hippocampus and the neocortex is tightly correlated with neuronal activity and upregulated by physiological stimuli, such as exposure to a novel environment or during spatial learning (Guzowski et al. 1999; Vazdarjanova and Guzowski 2004) . At the molecular level, Arc gene expression is stimulated by massive synaptic activity or brain-derived neurotrophic factor (BDNF) in both cultured neurons (Rao et al. 2006; Yasuda et al. 2007 ) and in vivo (Ying et al. 2002) . Several cis-acting sequences that are responsible for activity-induced Arc expression are located upstream of the Arc transcription start site (Li et al. 2005; Kawashima et al. 2009; Pintchovski et al. 2009; Fukuchi et al. 2015) . The synaptic activityresponsive element (SARE) is one of the most critical enhancer elements within the Arc promoter in response to synaptic activity (Kawashima et al. 2009 ). Bioinformatics and biochemical analyses revealed that SARE contains the binding sites for cAMP response element-binding protein (CREB), myocyte enhancer factor 2 (MEF2) and serum response factor (SRF) (Kawashima et al. 2009 ) and SARE is not confined to the Arc gene, but also exists in neuronal plasticity-or neurological disorder-related genes (Rodr ıguez- Tornos et al. 2013) .
SRF is known to bind to a CC(A/T) 6 GG box within the SARE of the Arc gene (Kawashima et al. 2009; Pintchovski et al. 2009) . SRF knockout mouse studies revealed that SRF is involved in the activity-dependent expression of SRFtarget IEGs (Ramanan et al. 2005) , synaptic plasticity (Etkin et al. 2006) , neuronal migration, and neuronal circuitry formation (Alberti et al. 2005; Kn€ oll et al. 2006) , indicating that SRF-mediated gene expression plays crucial roles in many aspects of brain function. It is reported that activitydependent Arc expression via SRF is critical for long-term depression in cultured cerebellar Purkinje cells (Smith-Hicks et al. 2010) .
Recently, it has become evident that SRF-mediated gene transcription requires additional factors, namely SRF cofactors. SRF cofactors are classified into at least two types. One type comprises the ternary complex factors (TCFs), which bind to the sequence GGAA/T, adjacent to the SRF binding site, to form a ternary complex with SRF (Buchwalter et al. 2004) . The other type of SRF cofactor includes myocardin and megakaryoblastic leukemia (MKL) family members, such as MKL1 [also termed megakaryocytic acute leukemia, myocardin-related transcription factor-A (MRTFA), basic SAP and coiled-coil domain (BSAC)] and MKL2 (also termed MRTFB) (Wang et al. 2002; Sasazuki et al. 2002; Cen et al. 2003; Selvaraj and Prywes 2003; Cen et al. 2004; Pipes et al. 2006) . MKL is an important regulator of neuronal morphology (Kalita et al. 2012; Shiota et al. 2006; Ishikawa et al. 2010; O'Sullivan et al. 2010; Mokalled et al. 2010 ). Our previous studies determined the structure of disordered RPEL motifs in MKL1 (Mizuguchi et al. 2014) and demonstrated that MKL1 isoforms differentially regulate dendritic complexity (Ishikawa et al. 2013 . In addition to the physiological roles of MKL in neurons, neuropathological features of MKL have been reported, such as single nucleotide polymorphisms of the MKL1 gene in patients with schizophrenia (Luo et al. 2015) and the MKL2 mutation as a possible causative candidate for autistic spectrum disorder (Holt et al. 2010; Neale et al. 2012) . Thus, studies on the molecular functions of MKL in neurons contribute to better understanding of the mechanisms underlying brain functions and the etiology of neurological disorders. However, it is still unknown how MKL regulates neuronal SRF-target genes in response to stimulation.
In this study, we focused on the Arc gene and investigated whether it is a MKL-target gene. Our findings indicate that another SRF cofactor, TCF, is not involved in BDNFinduced activation of Arc gene transcription in cortical neurons very much. Instead, we demonstrated involvement of MKL2, but not MKL1. Our findings not only indicate distinct usage of the SRF cofactor in a specific subset of SRF-target genes, but also uncover the neuronal functions of MKL2 at the transcriptional level.
Methods

Animals
Pregnant female Sprague-Dawley (SD) rats and embryos of SD rats were purchased from Japan SLC (RRID:RGD_12910483, Hamamatsu, Japan). The maintenance conditions of SD rats were 23-25°C, 45-65% humidity, 12 h/12 h light-dark cycles, and free access to food and autoclaved water (pH 2.5-3.0). All experiments were approved by the Animal Experimentation and Ethics Committee of the Kitasato University School of Medicine and the Animal Care and Experimental Committee of the University of Toyama, Sugitani Campus (approval numbers: S-2008 PHA-3, S2009 PHA-23, S2010 PHA-1, A2011 PHA-5, A2012 PHA-1, A2013 PHA-4, and A2016 PHA-8). Every effort was made to minimize the number of animals used and their suffering. For example, pregnant female SD rats were anesthetized by intraperitoneal administration of pentobarbital sodium salt (50 mg/kg) during the operation and decapitation. Embryos of SD rats were decapitated soon after removal from the uterus.
Reagents
Human recombinant BDNF protein was provided by Dainippon Sumitomo Pharma (Osaka, Japan). BDNF was used at 100 ng/mL as described previously (Yasuda et al. 2007 ). TrkB-Fc, a BDNF scavenger (cat number, 688-TK-100, RRID: unknown), was purchased from R&D Systems (RRID:SCR_006140, Minneapolis, MN, USA). (-)-Bicuculline methochloride (Bic) (cat number, ab120110;RRID: unknown) and 4-aminopyridine (4AP) (cat number, 275875-1G; RRID: unknown) were obtained from Abcam (RRID: SCR_012931, Cambridge, UK), and Sigma-Aldrich (RRID: SCR_008988, St. Louis, MO, USA), respectively.
Plasmids
A series of Arc gene promoter-driven luciferase reporter constructs, Arc7000 and SARE-mincytomegalovirus (SARE-minCMV), and mutants thereof, were used as previously described (Kawashima et al. 2009 ). Arc7000TCFm has a mutation in the TCF-binding site within SARE and was created by XhoI/SwaI-digestion, mutagenesis of the shorter fragment using a KOD-Plus mutagenesis kit (SMK-101, Toyobo, Osaka, Japan) and insertion of the fragment back into Arc7000. SARE-minCMV with a mutation in the TCF-binding site within SARE was created by mutagenesis using a KOD-Plus mutagenesis kit. An internal control vector for luciferase gene reporter assays, RSV-b-gal, was used as described previously (Ishikawa et al. 2010) . The expression vector for knocking down MKL1 and MKL2 produces small hairpin RNAs against MKL1 and MKL2 (shMKL1 and shMKL2) (Ishikawa et al. 2010 (Kaneda et al. 2018) . The vector for enhanced green fluorescent protein (pEGFP-C1) was purchased from Clontech (6084-1, Polo Alto, CA, USA). The FLAG-tagged empty vector (pFLAG-CMV2) was purchased from Sigma, St Louis, MO, USA (E7033). The FLAG-tagged mouse Elk1 construct (FLAG-Elk1) was constructed by amplification of 7-week-old hippocampal Elk1 cDNA with Pfu polymerase (Promega, Madison, WI, USA) and Elk1 primers (Table 1) , and insertion of the PCR product into the pGEM-T Easy vector (Promega). After double digestion of the plasmid with HindIII/XbaI, the fragment was inserted into the HindIII/XbaI sites of pFLAG-CMV2. The myc-tagged empty vector was purchased from Clontech (635689). The myc-tagged mouse MKL2 was constructed and used as described previously (Ishikawa et al. 2010) .
Antibodies
Rabbit anti-Arc antibody (1 : 2000 dilution) was used for western blotting as previously described (Okuno et al. 2012 14 lg/mL for immunostaining; 10 lg for chromatin immunoprecipitation (ChIP) assays; 0.114 lg/ mL for western blotting] and anti-MKL2 (2.5 lg/mL for immunostaining; 10 lg for ChIP assays; 0.25 lg/mL for western blotting) antibodies were generated in-house and evaluated (Kaneda et al. 2018) .
Cell culture
Primary cultures of rat cortical neurons were prepared from rat embryos (embryonic day 17) according to a previously described method (Tabuchi et al. 2005 ) with minor modifications. Cells were plated at 2 9 10 6 cells per well in 6-well plates coated with poly-D-lysine (P6407, Sigma) and maintained in media containing neurobasal medium (21103-049, Invitrogen, Carlsbad, CA, USA), 1 9 B27 supplement (17504-044, Invitrogen), 2 lg/mL gentamicin and 0.5 mM glutamine. For ChIP assays, cells were seeded at 5 9 10 6 cells per 60-mm dish coated with poly-L-lysine (P9155, Sigma-Aldrich). Half of the conditioned medium was exchanged for fresh medium every 3 days. For immunostaining, cells were seeded at 3 9 10 5 cells per well in 12-well plates containing coverslips coated with poly-D-lysine (P6407, Sigma-Aldrich). A B27-Electrophysiology Kit supplemented with 0.5 mM Gluta-MAX-I and 2 lg/mL gentamicin (A14137-01, Gibco/Life Technologies, Carlsbad, CA, USA), was used for cell culture. Half of the medium was replaced at 1, 4, 7, 10, 12, and 15 days. The detailed procedure has been described previously (Kikuchi et al. 2017) .
Quantitative real-time PCR (qPCR)
qPCR was performed using the Mx3000p Real-Time PCR system (Stratagene, La Jolla, CA, USA) with Brilliant II SYBR Green QPCR master mix (600828, Agilent, St. Clara, CA, USA) or SYBR Select Master Mix (cat number, 4472908; ThermoFisher Scientific K.K., Waltham, MA, USA) to detect GAPDH in Fig. 6 , according to the manufacturers' instructions. qPCR with Brilliant II SYBR Green QPCR master mix involved preheating samples at 95°C for 10 min followed by three steps: 95°C for 45 s, 56°C for 45 s (Arc) or 58°C for 45 s (GAPDH) and 72°C for 1 min for 45 cycles. qPCR with SYBR Select master mix was performed at 50°C for 2 min and then 95°C for 2 min, followed by 40 cycles of 95°C for 15 s, 58°C for 15 s, and 72°C for 1 min. For measurement of mRNA levels, total RNA was extracted from cortical neurons using TRIsure (BIO-38032, Bioline, London, UK), and cDNA was synthesized with SuperScript II (18064-014, Invitrogen). qPCR primers for Arc and GAPDH are described in Table 1 (Primers for qPCR). The pUC118 backbones of the GAPDH and Arc partial cDNA plasmids were used to generate standard curves with the primers for Arc and GAPDH (Table 1 , Primers of vector construction for standard curve of qPCR).
Western blotting
Cortical neurons were harvested and subjected to western blotting as described previously (Ishikawa et al. 2010) . In brief, cell lysates were prepared in extraction buffer consisting of 25 mM HEPES, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.1% Triton X-100, 20 mM b-glycerophosphate, 10 lg/mL aprotinin, 10 lg/mL leupeptin, 1 mM sodium orthovanadate, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride (PMSF). After centrifugation, the supernatants were mixed with an equal volume of 2 9 Laemmli buffer (Bio-Rad Laboratories, Hercules, CA, USA) and separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (10% SDS gel for detection of Arc, a-tubulin; 5% SDS gel for detection of MKL). Proteins were transferred onto polyvinylidene fluoride membranes (Bio-Rad Laboratory) and incubated with antiArc or anti-a-tubulin antibodies. The membranes were further incubated with horseradish peroxidase-conjugated rabbit or mouse anti-IgGs. Protein signals were developed by enhanced chemiluminescence (ECL western blotting detection reagents; RPN2209, GE Healthcare, Little Chalfont, UK). For endogenous Arc protein detection, the signal was further enhanced using the Can Get Signal (NKB-201, Toyobo, Osaka, Japan).
Transfection into cortical neurons
Cortical neurons, cultured for 7 days, were transfected using the calcium phosphate precipitation method as described previously (Tabuchi et al. 2005; Ishikawa et al. 2010) . In brief, the plasmid solution in 0.25 M CaCl 2 was mixed with an equal volume of 2 9 HBS pre-warmed at 37°C and then incubated at room temperature to precipitate the DNA. Cortical neurons washed with and preincubated in Dulbecco's modified Eagle's medium for 1 h in a 10% CO 2 incubator were treated with the DNA precipitates for 20 min. Then, cells were washed three times with Dulbecco's modified Eagle's medium and incubated in conditioned medium before use in drug treatments. For immunostainings, cortical neurons cultured for 13 days were transfected.
Reporter assay
Transcriptional activity was monitored using either firefly luciferase or b-galactosidase activity as described previously (Ishikawa et al. 2010) . In almost all experiments, cortical neurons were transfected with plasmids (4.2 lg/well) in the following ratios: reporter vector: expression vector = 1 : 3; firefly luciferase: b-galactosidase = 5 : 1. The fold increase in reporter activity in response to BDNF varied between Figs 2, 3, and 5. This may be due to different amounts of plasmid used or the use of different primary cultures. 
Immunoprecipitation
Immunoprecipitation was performed using a Dynabeads Co-immunoprecipitation kit (143-21D, Life Technologies), according the manufacturer's instructions with minor modifications. First, bead-antibody coupling (6 lg antibody/1 mg beads) was carried out at 1 day before harvesting cortical neurons. In brief, 200 lL of the total reaction mixture (C1 + C2 + antibodies) was incubated at 37°C overnight with rotation. The complex was washed with 800 lL HB, 800 lL LB, and 800 lL SB twice. The complex was suspended in 800 lL SB, rotated at 25°C for 15 min, re-suspended in 100 lL SB, and then stored at 4°C until use. Cortical neurons (2.4 9 10 7 cells) were washed with phosphate buffered saline (PBS) and harvested in 720 lL PBS containing 20 lM bglycerophosphate, 10 lg/mL aprotinin, 10 lg/mL leupeptin, 1 mM vanadate, and 100 mM PMSF. After centrifugation, the precipitate was suspended in 900 lL 1 9 IP containing 100 mM NaCl, 20 lM b-glycerophosphate, 10 lg/mL aprotinin, 10 lg/mL leupeptin, 1 mM vanadate, and 100 mM PMSF, and incubated at 4°C for 15 min. Some of the supernatant (60 lL) was used for the control (input). The remaining supernatant (800 lL) was mixed with the bead-antibody complex, which was pre-washed with 900 lL 1 9 IP, resuspended, and rotated at 4°C overnight. The precipitate was washed three times with 200 lL 1 9 IP, resuspended in 1 9 last wash buffer (LWB) containing 0.02% Tween-20, and then rotated for 5 min. The precipitate was transferred to a new tube and resuspended in 60 lL 1 9 IP. The samples and the control inputs were subjected to western blotting.
ChIP assay
The ChIP assay was performed using the Magna ChIP TM G One-Day Chromatin Immunoprecipitation Kits (17-611, Millipore, Temecula, CA, USA), Chromatin IP DNA purification Kit (58002, Active Motif, Carlsbad, CA, USA), according to the manufacturer's instructions with minor modifications. Cortical neurons (5 9 10 6 cells/dish at 9 days in vitro) were stimulated with 100 ng/mL BDNF for 30 min. Then, the cells were fixed with 1% (v/v) formaldehyde at 25°C for 10 min and incubated with 1 9 glycine at 25°C for 5 min. Cells in two dishes were collected in ice-cold PBS containing a protease inhibitor cocktail. After centrifugation, the cells were resuspended in 500 lL Cell Lysis Buffer. After washing and further centrifugation, nuclear extracts were prepared by dissolving the cell suspension in 500 lL Nuclear Lysis Buffer. Cell lysates were sonicated 30 times for 30 s each sonication with 1 min intervals using a Bioruptor UCD200T (BM Equipment, Tokyo, Japan). After centrifugation, the supernatants were diluted 20-fold with ChIP Dilution Buffer to 500 lL and pre-cleared with 20 lL Protein G at 4°C for 1 h on a rotator. The supernatants were incubated at 4°C overnight with the immunocomplex of Magnetic Protein G beadsantibodies on a rotator. The precipitated chromatin complex was washed with four kinds of buffer by rotating and then eluted in 100 lL ChIP Elution Buffer. The sample was digested with 1 lL proteinase K for 2 h at 62°C and then denatured for 10 min at 95°C. The resultant sample was purified with a Chromatin IP DNA purification Kit and stored at À30°C until PCR analysis. PCR was performed with Go Taq DNA polymerase (M8291, Promega) at 95°C for 2 min followed by 32 cycles of 95°C for 45 s, 58°C for 45 s, and then 72°C for 1 min, followed by 72°C for 5 min, 4°C for 10 min, and a final holding temperature of 15°C. PCR primers for ArcSARE and GAPDH are described in Table 1 . The PCR products were electrophoresed on a 2% (w/v) agarose gel and visualized with ethidium bromide.
Immunostaining
The immunostaining protocols have been described previously (Ishikawa et al. 2010; Kaneda et al. 2018) . In brief, cortical neurons were fixed with PBS(+) containing 4% formaldehyde and 4% sucrose for 15 min and then permeabilized in PBS containing 0.3% Triton X-100, 3% bovine serum albumin, and 3% normal goat serum for 1 h. Then, the cells were incubated with anti-MKL1 or anti-MKL2 and anti-GFP antibodies at 4°C overnight. After washing in PBS, the cells were incubated with CF594-and CF488A-conjugated secondary antibodies for 1 h at 25°C. Nuclei were counterstained with 300 nM 4 0 ,6-diamidino-2-phenylindole (RRID:AB_2629482, D1306, Molecular Probes, Eugene, OR, USA) for 10 min at 25°C. Images were captured under an LSM780 confocal microscope (Carl Zeiss, Oberkochen, Germany). To quantify the effect of knocking down MKL proteins, color images of MKL and GFP staining were converted into gray scale images, and the signal intensities were measured by ImageJ software (RRID:SCR_003070, https://imagej.nih.gov/ij/). Finally, the percentages of GFP-positive neurons versus GFP-negative neurons (red arrowheads) were calculated.
Statistical analysis
Bar graphs show the mean AE standard deviation (SD) of independent wells from one experiment of cell culture (n = 3-5 in Fig. 1 ; n = 3 in Fig. 2 ; n = 3 or 4 in Fig. 3 ; n = 3 in Fig. 5 ; n = 3-9 in Fig. 6 , the 'n' means the number of wells). We repeated the same experiment described above at least twice and successfully obtained the statistical reproducibility for explanation of the results section. A description is also included in the corresponding figure legend. There was a significant interaction in almost all experiments except for Fig. 6b and c (the p-value is shown in corresponding figures). Power analyses were performed by G*Power software (RRID:SCR_013726, http://www. gpower.hhu.de; Faul et al. 2007 Faul et al. , 2009 . Results are summarized in Table S1 . Because our sample size was very small, a normal distribution could not be evaluated accurately. Therefore, we did not formally test for a normal distribution. We performed a variance test. According to the results of the variance test, we selected and performed a significance test. All statistical analyses are summarized in Table S2 . All statistical significance was analyzed by one-way or two-way analysis of variance (ANOVA) and a Student's t-test or Welch's t-test with Bonferroni's correction, Scheffe's F-test, or Tukey-Kramer's test. Blinding and randomization procedures were unnecessary because bar graphs were generated automatically and any sampling bias did not arise. Detailed descriptions including total sample size are included in each figure legend. A test of outliers was not conducted.
Results
Contribution of the SARE to BDNF-induced Arc gene expression Administration of BDNF to cortical neurons markedly promotes Arc gene expression (Yasuda et al. 2007; Pintchovski et al. 2009 ). To examine the peak time of BDNFinduced Arc gene expression, a time-course of Arc mRNA levels, protein levels and promoter activity after BDNF administration to primary cultured cortical neurons was performed. Arc mRNA levels reached a peak at 1 h after BDNF-treatment, were reduced at 3 h and gradually reduced further over the next 9 h (Fig. 1b) . The level of GAPDH mRNA remained constant in the presence or absence of BDNF (Fig. 1b) . Arc protein levels were also drastically induced by BDNF-treatment with peak levels at 3 h (Fig. 1c) . Synaptic activity strongly induces Arc gene expression through the SARE (Kawashima et al. 2009 ). Therefore, the luciferase . Total RNA was isolated at the indicated times and qPCR was performed. Graphs represent the mean AE SD. from three to five independent wells from one experiment of cell culture (n = 3-5 samples). The table indicates the expression levels of GAPDH. Statistical analysis was performed by two-way ANOVA (there was a significant interaction between time and BDNF: p < 0.0001) followed by a Welch's t-test with Bonferroni's correction (***p < 0.00025 vs. control). G*Power was used to calculate the post-hoc power (1-b) (Table S1 ). Zero time indicates prestimulation of BDNF. Statistical analysis was performed for all results except for the value at 0 h. Statistics are not shown for the control group. (c) Arc protein expression. BDNF-stimulation [BDNF (+)] was performed using the protocol shown in (b). Cell lysates were prepared at the indicated times. a-tubulin was used as the internal control. Full blot images are provided in Figure S1 .
gene fused to the mouse Arc gene (Arc7000Luc) and the luciferase gene driven by the minimum CMV promoter fused to the mouse SARE (SARE-minCMV Luc) was used to measure the enhancer activity of the SARE (Fig. 2a) . Strong and transient responsiveness to BDNF was observed for SARE-minCMVLuc (Fig. 2c) and Arc7000 Luc (Fig. 2d) . The activation of the luciferase gene was maximal at 3 h ( Fig. 2c and d) . Therefore, these findings indicate that the SARE is responsive to BDNF-stimulation to up-regulate Arc gene transcription. values of BDNF (+) Luciferase and b-galactosidase activities were measured at the indicated times. Graphs represent the mean AE SD. of three independent wells from one experiment of cell culture (n = 3 samples). Statistical analysis was two-way ANOVA (there was a significant interaction between time and BDNF: p < 0.0001) followed by a Welch's t-test with Bonferroni correction (**p < 0.05/7 vs. control;**p < 0.01/7 vs. control; ***p < 0.001/7 vs. control). G*Power calculated the post hoc power (1-b) (Table S1 ). Zero time means prestimulation of BDNF. Every statistical analysis was performed except for the value at 0 h. Statistics are not shown for the control group.
Effects of CREB-, MEF2-, SRF-, and TCF-mutants on BDNFinduced Arc promoter activation Next, we tested whether the CREB-, MEF2-, SRF-, or TCFbinding sites in the SARE are required for Arc promoter activation by BDNF. Luciferase reporter vectors of the wild type or mutants are illustrated in Fig. 3a . To focus on the importance of the SARE for Arc transcription, we analyzed SAREminCMV. The CREB-and MEF2-binding site mutants caused a decrease in BDNF-induced Arc promoter activation (Fig. 3c) . In contrast, no BDNF-induced activation of the reporter was (Table S1 ).
observed with the SRF-binding site mutant. (Fig. 3c) . We also measured the induction levels of wild-type and mutant Arc7000 (Fig. 3d) . For the CREB, MEF2, and SRF mutants, the levels of fold-induction were significantly decreased, compared with wild type. Taken together, these findings suggest that CREB-, MEF2-, and SRF-binding sites are involved in Arc gene activation and that the SRF-binding site may be the most critical for the responsiveness of the SARE to BDNF. Mutation of the TCF-binding site did not reduce BDNF-induced Arc promoter activity ( Fig. 3c and d) .
Recruitment of MKL to the SARE of the Arc gene
The SARE of the Arc gene contains an SRF-binding site Therefore, MKL may be able to access the SRF-binding site. Thus, we further examined whether the recruitment of MKL to chromatin including the SARE of the Arc gene was regulated by BDNF. Previously, we reported the generation and evaluation of antibodies against MKL1 and MKL2 ( Kaneda et al. 2018) . Our western blotting revealed that the anti-MKL1 antibody does not recognize MKL2, and the anti-MKL2 antibody does not recognize MKL1 (Kaneda et al. 2018) . In addition, according to full blot images, other major extra bands were not detected (Supplementary information, Kaneda et al. 2018) . Immunoprecipitation revealed that the antibodies against MKL1 and MKL2 precipitated MKL1 and MKL2 proteins, respectively, indicating that they were appropriate for immunoprecipitation (Fig. 4b) . Thus, we performed ChIP assays using these antibodies. Bands were not observed using control IgG (Fig. 4c, IgG) . The bands of MKL1 antibody-treated samples were observed in the absence or presence of BDNF (Fig. 4c, lanes 5 and 6) . Recruitment of MKL2 was also observed, although the intensity of the band was faint and unchanged in the absence or presence of BDNF (Fig. 4c, lanes 7 and 8) . The negative control (water) displayed no bands (Fig. 4c, rightmost lane) . In addition, bands did not appear in MKL2 antibody-treated samples when the immunoprecipitated samples were amplified with primers for GAPDH (Fig. 4c, bottom image) . Faint bands were observed MKL1 antibody-treated samples (Fig. 4c, bottom image) .
Involvement of MKL2, but not MKL1, in BDNF-induced activation of SARE in the Arc gene As shown in Fig. 4 , MKL bound to the SARE of Arc gene. This finding prompted us to investigate the role of MKL in BDNF-induced SARE activation using RNA interference (RNAi)-mediated MKL knockdown. We initially confirmed that expression of shRNAs against MKL1 (shMKL1) and MKL2 (shMKL2) specifically decreased the levels of endogenous MKL1 and MKL2 proteins in cortical neurons, respectively (Fig. 5b) . The reductions of MKL1 and MKL2 protein levels after transfection of shMKL1 and shMKL2 were quantified by measurement of the signal intensities of MKL in GFP-positive and GFP-negative neurons.
Immunostained endogenous MKL1 was reduced by shMKL1 (79.60%), but not shR-luc control (107.5%) or shMKL2 (103.1%). Immunostained endogenous MKL2 was reduced by shMKL2 (55.59%), but not shR-luc control (97.43%) or shMKL1 (94.15%) (Fig. 5b) . Thus, the shRNA vectors properly and specifically targeted MKL1 and MKL2 expression in cultured cortical neurons. Using these vectors, we examined the involvement of MKL in BDNF-induced SARE activation. RNAi-mediated knockdown of MKL1 did not affect BDNF-induced SARE activation, but knockdown of MKL2 reduced the activation (Fig. 5d) . This finding suggests that MKL2 plays a critical role in activating the Figure S1 . (c) Cortical neurons (9 DIV) were stimulated with (+) or without (-) 100 ng/mL brain-derived neurotrophic factor (BDNF) for 30 min and then samples were prepared and subjected to ChIP assays. Amplified and visualized PCR products. Control IgG: IgG; sample without immunoprecipitation (Input); samples treated with anti-MKL1 (MKL1) or anti-MKL2 (MKL2) antibodies. Upper and lower images show PCR products using primers for amplification of SAREs in Arc and GAPDH genes, respectively. Full gel images are provided in Figure S1 .
SARE of the Arc gene. As shown in Fig. 3c and d, the mutation in the TCF-binding site did not inhibit BDNFinduced Arc SARE activation. Therefore, we examined the effect of Elk1, a member of the TCF SRF cofactor family, on the Arc SARE, in addition to MKL2. Overexpression of FLAG-Elk1 slightly induced Arc SARE activation (Fig. 5e) , whereas overexpression of myc-MKL2 drastically induced Arc SARE activation (Fig. 5f ). These findings support that the Arc SARE is an MKL2-target element and there is little, if any, effect of another SRF cofactor, Elk1, on Arc SARE activation.
Inhibition of synaptic activity-induced Arc SARE by MKL2 knockdown, but not by a BDNF scavenger In this study, we focused on BDNF-induced Arc gene expression. The Arc gene is also known to be induced by synaptic activation through treatment with bicuculline (Bic) and 4-aminopyridine (4AP) (Kawashima et al. 2009 ). Bic treatment may cause chemical long-term potentiation and BDNF release (Reimers et al. 2014) . Next, we examined the effect of a BDNF scavenger, TrkB-Fc, on Arc gene induction mediated by synaptic activation to determine whether released BDNF influences Arc gene induction. (Table S1 ).
Administration of TrkB-Fc did not inhibit the increase of Arc mRNA expression (Fig. 6b) or activation of the Arc SARE (Fig. 6c) induced by Bic/4AP treatment. These findings suggest that released BDNF is not strongly involved in Arc gene induction under synapse-activated conditions evoked by Bic/4AP. Furthermore, we examined whether MKL2 was involved in activation of the Arc SARE induced by Bic/4AP. As shown in Fig. 6d , the inhibitory effect of shMKL2 on Bic/4AP-induced Arc SARE activation was partial, but significant. Therefore, MKL2 may also mediate synaptic activity-induced Arc gene expression.
Discussion
The SARE in the Arc gene promoter is involved in the response to synaptic activity, and CREB-, MEF2-, and SRFbinding sites are cooperatively involved (Kawashima et al. 2009 ). Thus, we hypothesized that SRF coactivator MKL was involved in the SARE of the Arc gene. To test this hypothesis, we designed and executed the experimental flowchart shown in Figure S2 . We found that the SARE is responsive to BDNF stimulation, and that the CREB-, MEF2-and SRF-binding sites contribute to the induction. Therefore, these findings suggest that a common signaling pathway and three transcription factors are used for induction of Arc after stimulation by synaptic activity or BDNF.
Studies on the brain of SRF KOs have shown that activitydependent expression of IEGs such as c-fos and Arc as well as neuronal plasticity require SRF (Ramanan et al. 2005) . In addition, the mutant mice carrying the inactivated SRFbinding site of SARE of Arc gene reduced long-term depression, further supporting a critical role for SRF/serum response element of Arc gene for neuronal plasticity (SmithHicks et al. 2010) . However, little is known about how the SARE transcriptional switch of Arc is turned on or off by SRF cofactors. In this study, we found that the SRF-binding site in the SARE was the most effective among CREB, (Table S1 ).
MEF2, and SRF binding sites for BDNF-induced Arc gene activation (Fig. 3) . Mutation of the TCF-binding site, which is adjacent to the SRF-binding site in the SARE, did not decrease BDNF-induced Arc gene transcription (Fig. 3) . A recent study has demonstrated that BDNF-mediated Arc gene expression is controlled by MSK1 (Hunter et al. 2017) . Hunter et al. (2017) also discussed the possible involvement of Elk1, a TCF family member, in BDNF-mediated Arc gene expression, because of the direct activation of Arc mRNA transcription by ERK1/2. However, direct evidence of Elk1 involvement in Arc gene expression was not shown in the study by Hunter et al. Therefore, we constructed FLAGtagged Elk1 for use in a luciferase assay. As shown in Figure 5e , Elk1 slightly activated the Arc SARE. In contrast, MKL2 drastically induced Arc SARE activation (Fig. 5f ). Taken together with mutation analysis of the TCF-binding site (Fig. 3) , there is little, if any, involvement of Elk1 in upregulation of Arc gene transcription via a SARE.
Therefore, rather than involvement of TCF in Arc gene transcription, another SRF cofactor, MKL, emerged as the regulator of the Arc gene. Although a study has suggested that MKL1 might recover the expression level of the Arc gene repressed by amyloid b (Αb 25-35 )-administration, these findings arose from overexpression of MKL1 (Zhang et al. 2016) . In this study, we focused on the regulatory function of both endogenous and exogenous MKL family members in Arc gene transcription. To test whether endogenous MKL binds to the SARE of the Arc gene, we performed ChIP assays (Fig. 4) . Our antibodies against MKL1 and MKL2 were appropriate for immunoprecipitation (Fig. 4b) and used for the analysis. In terms of MKL2, we observed recruitment to chromatin of the SARE in the Arc gene, but not that in the GAPDH gene (Fig. 4c) . In MKL1 antibody-treated samples, PCR products amplified by Arc primers and GAPDH primers for negative control were observed (Fig. 4c) . Therefore, this observation does not clearly demonstrate that MKL1 is involved in binding of the SARE of the Arc gene. Taken together, Our ChIP assay, at least revealed MKL2 recruitment to the SARE in the presence or absence of BDNF. The intensity of the bands in the presence of BDNF was almost the same as that in the absence of BDNF (Fig. 4c) . This finding suggests that BDNF does not alter the nuclear/cytoplasmic ratio of MKL molecules in cortical neurons. Our previous study suggests that MKL1 and MKL2 are localized in both the cytoplasm and nucleus, and MKL2 is more nuclear rather than MKL1 in cortical neurons (Kaneda et al. 2018) . Taken together, we hypothesize that nuclear MKL2 is modified by BDNF stimulation in cortical neurons. Although little is known about modifications of MKL2, such as phosphorylation, several studies indicate that MKL1 has multiple phosphorylation sites (Miralles et al. 2003; Panayiotou et al. 2016) . In addition, a study has indicated that BDNF promotes phosphorylation of MKL1 in neurons (Kalita et al. 2006) . Similar to MKL1, MKL2 might be phosphorylated and thereby activated by BDNF. To address this issue, further studies, especially to determine phosphorylation of MKL2 induced by BDNF, would be required.
We further performed RNAi experiments to evaluate shRNA effects (Fig. 5b) and found that MKL2, but not MKL1, contributed to activation of the SARE in the Arc gene by BDNF (Fig. 5d) . Furthermore, even though MKL2 was overexpressed in cortical neurons, the Arc SARE was positively up-regulated (Fig. 5f ). Taken together, these findings suggest that MKL2 binds to and activates the SARE of the Arc gene. Although MKL1 and MKL2 are classified in the same family, they may be used differently in transcriptional regulation of SRF-target genes. Our findings suggest that the Arc SARE is an MKL2-target enhancer.
In addition to BDNF treatment, we administered Bic and 4AP to cortical neurons to induce synaptic activation and Arc gene transcription (Fig. 6 ). Bic/4AP triggers activation of ionotropic glutamate receptors (Kawashima et al. 2009 ). Bic/ 4AP caused an increase of Arc mRNA expression and activation of the Arc SARE, which were not blocked by a BDNF scavenger, TrkB-Fc ( Fig. 6b and c) . These findings suggest that endogenous BDNF released by synaptic activity is not strongly involved in Arc gene induction under the condition evoked by Bic/4AP. There is one possibility to explain these findings. A previous study has demonstrated that not only the Arc SARE (distal enhancer), but also a proximal promoter are responsive to exogenous BDNF (Fukuchi et al. 2015) . Even though endogenous BDNF is scavenged by TrkB-Fc, synaptic activity and Ca
2+
-signaling evoked by Bic/ 4AP may be sufficient to activate Arc gene transcription by predominantly using SARE, but not via a proximal promoter.
We further determined whether MKL2 was also involved in activation of the Arc SARE by Bic/4AP. ShMKL2 partially blocked Arc SARE activation induced by Bic/4AP (Fig. 6d) , suggesting that MKL2 mediates synaptic activityinduced Arc SARE activation.
ShMKL2 or shMKL1/shMKL2 reduced BDNF-or synaptic activity-induced Arc gene transcription. However, the inhibitory effect was partial (Figs. 5d and 6d ). This finding implies that other transcriptional cofactors are required. One of the CREB cofactors, CREB-regulated transcription coactivator 1 (CRTC1), is required to activate the Arc gene transcription (Nonaka et al. 2014 ). Thus, not only three transcription factors (CREB, MEF2, and SRF), but also their cofactors may cooperatively organize the transcriptional complex to fully activate the Arc gene.
In this study, we propose that the Arc SARE is an MKL2 target. There is other supporting evidence that Arc may be an MKL target gene (Mokalled et al. 2010) . The supplementary material regarding microarray data of cortical samples derived from control and MKL double KO brains at P0 revealed that expression of the endogenous Arc gene was down-regulated (fold change: -1.5) in MKL double KO brains (Mokalled et al. 2010) . Our study, at least in part, contributes to further understanding of the molecular mechanism underlying the MKL-SRF-Arc axis.
The SARE exists not only in the Arc gene but also in other plasticity-related genes and in genes involved in mental retardation and cognitive disorders (Rodr ıguez-Tornos et al. 2013). Thus, analyzing transcriptional regulation via the SARE is relevant for better understanding of synaptic plasticity and neurological disorders. Furthermore, MKL2 mutations have been found in patients with autistic spectrum disorder (Holt et al. 2010; Neale et al. 2012) . Therefore, mutation of MKL2 may possibly result in dysregulation of IEGs, such as Arc, and dysfunctional neurons. Program, B. Asia-Africa Science Platforms. The authors have no conflict of interest to declare. The authors declare that this study was not preregistered.
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